Merial on pets and vets -- an interview with Dr Jean-Louis Foraz
Article Abstract:
Dr. Jean-Louis Foraz of Merial, a US animal health products firm, is interviewed. He discusses Merial's products, sales, strategy, and plans to become more closely involved with the veterinarian sector. Merial expects that its sales of pet products will total $730 million in 2001, with the majority of this revenue provided by parasiticides.
Publication Name: Animal Pharm
Subject: Business
ISSN: 0262-2238
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Dechra's sales rise 7.5%
Article Abstract:
Dechra Pharmaceuticals' (Stoke-on-Trent, England) turnover grew 7.5% to UK pounds 156.4 million and operating profit rose 10% to UK pounds 8.2 million for year-ended June 30, 2001. The firm's activities for the year are briefly discussed.
Publication Name: Animal Pharm
Subject: Business
ISSN: 0262-2238
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
84% US sales growth, but for whom?
Article Abstract:
In the third financial quarter of 2001, an 84% increase in animal health sales was reported in the United States. Pfizer reported its sales were up 29% from the third quarter of 2000 to $254 million.
Publication Name: Animal Pharm
Subject: Business
ISSN: 0262-2238
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Medical supplies & devices. Investing in health sciences
- Abstracts: IASB is on its way. Battle of the regulators. Coping with compliance
- Abstracts: Fair values, wrong answers. Coast to coast
- Abstracts: A matter of interpretation. US dangles listing carrot. Blueprint for the future
- Abstracts: Earnings and risk changes surrounding primary stock offers. Disclosure practices of foreign companies interacting with U.S. markets